Wu XH - Search Results

1

Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma.

Wu S, Zhou Y, Hua HY, Zhang Y, Zhu WY, Wang ZQ, Li J, Gao HQ, Wu XH, Lu TX, Hua D. Wu S, et al. Among authors: wu xh. BMC Cancer. 2018 Oct 19;18(1):997. doi: 10.1186/s12885-018-4914-4. BMC Cancer. 2018. PMID: 30340560 Free PMC article.

2

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma.

Lu TX, Wu S, Cai DY, Hong TT, Zhang Y, Gao HQ, Hua HY, Wu XH. Lu TX, et al. Among authors: wu xh, wu s. BMC Cancer. 2019 Jun 8;19(1):553. doi: 10.1186/s12885-019-5758-2. BMC Cancer. 2019. PMID: 31176361 Free PMC article.

3

CD5⁺MYC⁺ predicts worse prognosis in diffuse large B-cell lymphoma.

Lu TX, Wu S, Zhou XY, Zhang Y, Hong TT, Cai DY, Hua HY, Qi XW, Wu XH. Lu TX, et al. Among authors: wu xh, wu s. Exp Mol Pathol. 2020 Feb;112:104326. doi: 10.1016/j.yexmp.2019.104326. Epub 2019 Nov 9. Exp Mol Pathol. 2020. PMID: 31706988

4

Development and validation of a nomogram to predict survival after curative resection of nonmetastatic colorectal cancer.

Hong T, Cai D, Jin L, Zhang Y, Lu T, Hua D, Wu X. Hong T, et al. Cancer Med. 2020 Jun;9(12):4126-4136. doi: 10.1002/cam4.3010. Epub 2020 Apr 21. Cancer Med. 2020. PMID: 32314876 Free PMC article.

5

Second-line epidermal growth factor receptor inhibitors followed by third-line pemetrexed or the reverse sequence: a retrospective analysis of 83 Chinese patients with advanced lung adenocarcinoma.

Hong T, Zhang R, Cai D, Wu X, Hua D. Hong T, et al. J Cancer Res Clin Oncol. 2012 Feb;138(2):285-91. doi: 10.1007/s00432-011-1084-z. Epub 2011 Nov 25. J Cancer Res Clin Oncol. 2012. PMID: 22116317

6

A novel systematic inflammation related index is prognostic in curatively resected non-metastatic colorectal cancer.

Hong T, Shen D, Chen X, Cai D, Wu X, Hua D. Hong T, et al. Am J Surg. 2018 Sep;216(3):450-457. doi: 10.1016/j.amjsurg.2017.07.021. Epub 2017 Jul 19. Am J Surg. 2018. PMID: 28743381

7

Three vascular endothelial growth factor polymorphisms (-460C>T, -2578C>A, 1612G>A) with cancer risk: a meta-analysis based on 30 case-control studies.

Hong TT, Cai DY, Wu XH, Hua D. Hong TT, et al. Among authors: wu xh. Cancer Invest. 2011 Aug;29(7):472-7. doi: 10.3109/07357907.2011.597811. Cancer Invest. 2011. PMID: 21740084

8

[Efficacy and safety of docetaxol, pemetrexed and EGFR-TKIs as second-line treatment for patients with advanced non-small-cell lung cancer].

Zhang RX, Cai DY, Wu XH, Hua D. Zhang RX, et al. Among authors: wu xh. Zhonghua Zhong Liu Za Zhi. 2012 Nov;34(11):869-72. doi: 10.3760/cma.j.issn.0253-3766.2012.11.016. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 23291140 Chinese.

9

Preoperative serum lipid profile and outcome in nonmetastatic colorectal cancer.

Hong TT, Shen D, Chen XP, Wu XH, Hua D. Hong TT, et al. Among authors: wu xh. Chronic Dis Transl Med. 2016 Dec 22;2(4):241-249. doi: 10.1016/j.cdtm.2016.11.015. eCollection 2016 Dec. Chronic Dis Transl Med. 2016. PMID: 29063049 Free PMC article.

10

Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status.

Hong T, Liu A, Cai D, Zhang Y, Hua D, Hang X, Wu X. Hong T, et al. Cancer Invest. 2013 May;31(4):279-85. doi: 10.3109/07357907.2013.789898. Cancer Invest. 2013. PMID: 23627410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

848 results

Search Page

Filters